CANCER CELL MARKET ANALYSIS

Cancer Cell Market, by Cancer Cell Type (Carcinomas, Sarcomas, Leukemia, and Others), by Application (Chemotherapy, Radiation Therapy, Immunotherapy, Hormone Therapy, Targeted Drug Therapy, and Others), by End User (Hospitals & Clinics, Specialty Clinics, and Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Dec 2020
Code : CMI4338
Pages :175
Formats :
Excel and PDF
Industry : Pharmaceutical

Cancer Cell MarketSize and Trends

The global cancer cell market is estimated to be valued at US$ 8,525.5 million in 2020 and is expected to exhibit a CAGR of 8.20 % during the forecast period (2020-2027).

Figure 1. Global Cancer Cell Market Value (US$ Mn), 2016-2027

Increasing prevalence of cancers such as lung cancer, breast cancer, and others is expected to propel growth of the global cancer cell market during the forecast period. For instance, according to the World Health Organization report published in 2018, stated that cancer is the second leading cause of death in people globally and caused around 9.6 million deaths, globally in the year 2018.

Furthermore, key companies focusing on inorganic strategies such as mergers and acquisitions to launch new targeted cell therapies for the treatment of people suffering from cancer, are expected to drive growth of the market. For instance, in 2018, Pfizer, Inc. announced its merger with Allogene to develop an investigational CAR-T cell therapy for the treatment of cancer.